Cargando…
Advances in virus research. Volume 54 /
Advances in Virus Research.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego :
Academic Press,
1999.
|
| Colección: | Advances in virus research ;
54. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Advances in Virus Research, Volume 54; Copyright Page; Contents; Chapter 1. The Life and Times of Adenoviruses; Text; References; Chapter 2. Role of Outer Capsid Proteins in Transmission of Phytoreovirus by Insect Vectors; I. Introduction; II. Localization of Structural Proteins in Particles of Phytoreovirus; III. Role of P2 Protein in Viral Infection of Insect Vector Cells; IV. Correlation between Infectivity nad Presence of P2 Protein in RGDV; V. P2 Protein Allowing RDV to Adsorb to Insect Vector Cells
- VI. Absence of P2 Protein Expression in transmission-Defective Isolate of RDVVII. P8 Outer Capsid Protein of RDV Involved in Viral Infection of Insect Vector Cells; VIII. Concluding Remarks; References; Chapter 3. Replication of Human Hepatitis Delta Virus: Influence of Studies on Subviral Plant Pathogens; I. Introduction and Scope; II. Early History; III. Transmission, Epidemiology, and Pathogenesis; IV. Initial Application of Molecular Virology; V. Initial Similarities to Plant Agents; VI . Subsequent Molecular Virology; VII. Subsequent Similarities to Plant Agents
- VIII. Conclusions and OutlookReferences; Chapter 4. Regulation of Human Cytomegolovirus Gene Expression; I. Introduction; II. Viral Entry; III. Immediate Early Events Mediated by Initial Virus-Host Interaction; IV. Utilization of Preexisting Nuclear Architecture by HCMV; V. Influence of Host Cell Cycle Phase on IE Gene Expression; VI. Major Immediate Early Gene Expression IE1/IE2 (UL123/122); VII. Other IE Gene Products; VIII. Activation of Early Genes; IX. Regulation of True Late Genes; X. Conclusions; References; Chapter 5. DNA Vaccines: A Review; I. DNA-Based Vaccines
- II. Serum Kinetics and Uptake MechanismsIII. Mechanism of Antigen Presentation; IV. Adjuvancy Effects of Bacterially Derived DNA; V. Immune Response to DNA-Based Vaccines; VI. Mucosal and Epidermal Delivery; VII. Transdermal Delivery; VIII. Cytokine Modulation of Immunity to DNA-Based Vaccines; IX. Safety; X. Future Directions; XI. Summary; References; Chapter 6. Epidemiological Risks from Mixed Virus Infections and Transgenic Plants Expressing Viral Genes; I. Introduction; II. Mixed Infections; III. Transgenic Plants; IV. Analysis of Risk and Proactive Risk Reduction; V. Concluding Remarks